04 September 2020: Original Paper
Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells
Zhuo-Qing Li 1BCDEF* , Hong Shen 2BCDE* , Kun-Xian Shu 3BCDF , Jian-Jun Li 1BCDF , Yin Tang 4BCD , Jing-Jing Su 4BCF , Jun Yan 1BCD , Jie Yang 3BCF , Ze-Qing Wang 1BCF , Yan Qiu 4BC , Yong Yang 1CF , Yang Liu 4CF , Yong Zhou 5BDEG*DOI: 10.12659/AOT.925013
Ann Transplant 2020; 25:e925013
Figure 3 E1B19K expression in cells detected using qPCR assay. (A – HepG2 cells, B – A549 cells, C – BGC-803 cells, D – HUVEC cells. 1 – cells without transfection, 2 – cells transfected with pAAV-IRES-ZsGreen, pHelper, and pAAV-RC, 3 – cells transfected with pAAV-HE1B19K-TE1A, pHelper, and pAAV-RC). *** p<0.0001 vs. pAAV-IRES-ZsGreen group in HepG2, A549, or BGC-803 cells.